Adrian Pona
Overview
Explore the profile of Adrian Pona including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Payne J, Habet K, Pona A, Feldman S
J Drugs Dermatol
. 2019 Aug;
18(8):756-770.
PMID: 31424707
BACKGROUND: Topical corticosteroids are efficacious treatment options for multiple dermatoses. However, ointments and cream corticosteroid vehicles can be cumbersome to patients and may act as a barrier to adherence. Foam...
22.
Johnson M, Pona A, Adler-Neal A, Kesty C, Cline A, Feldman S
J Cutan Med Surg
. 2019 Aug;
24(1):17-22.
PMID: 31409112
Background: Treatment of childhood atopic dermatitis (AD) is hindered by nonadherence, but caregiver reassurance may help overcome this hurdle. Objectives: To assess caregivers' willingness to treat childhood AD with a...
23.
Cohen S, Pona A, Cline A, Feldman S
Expert Rev Clin Immunol
. 2019 Jul;
15(8):809-811.
PMID: 31290340
No abstract available.
24.
Pona A, Haidari W, Kolli S, Feldman S
Dermatol Online J
. 2019 Mar;
25(2).
PMID: 30865402
Background: Patients with psoriasis have a growing interest in managing their disease through diet. Objective: This review paper aims to analyze dietary interventions for psoriasis and their outcome. Methods: Terms...
25.
Kolli S, Pecone D, Pona A, Cline A, Feldman S
Am J Clin Dermatol
. 2019 Jan;
20(3):345-365.
PMID: 30674002
Background: Topical retinoids are a first-line treatment for acne vulgaris. Objective: This systematic review aims to evaluate the efficacy, safety, and tolerability of topical retinoids approved in the United States...
26.
Kolli S, Amin S, Pona A, Cline A, Feldman S
Cutis
. 2018 Dec;
102(5S):21-25.
PMID: 30566553
Psoriasis is a chronic inflammatory disease with both a physical and psychosocial burden. To offer strategies for dermatology residents to assess and manage psychosocial aspects of psoriasis, a PubMed search...
27.
Pona A, Cline A, Kolli S, Taylor S, Feldman S
Dermatol Ther
. 2018 Dec;
32(2):e12786.
PMID: 30556246
To assess the possible clinical implication of Dragon's Blood in dermatology, a PubMed search was conducted using the keyword "Dragon's Blood," "Croton lechleri," and more. Dragon's Blood from C. lechleri...
28.
Kolli S, Gabros S, Pona A, Cline A, Feldman S
Ann Pharmacother
. 2018 Oct;
53(4):413-418.
PMID: 30345790
Objective: Tildrakizumab, an inhibitor of the p19 subunit of interleukin (IL)-23, was recently Food and Drug Administration (FDA) approved for patients with moderate to severe psoriasis. This article will review...
29.